US Patent 8722895 Prolyl hydroxylase inhibitors and method of use
Patent 8722895 was granted and assigned to Akebia Therapeutics on May, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8722895 Prolyl hydroxylase inhibitors and method of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
